Evidence map›Paper›PMID 21738737›Full record

ArticlePloS one2011

Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses.

Aditi Varthaman, Marc Clement, Jamila Khallou-Laschet, Giulia Fornasa, Anh-Thu Gaston, Michael Dussiot, Giuseppina Caligiuri, Harvey Cantor, Srinivas Kaveri, Antonino Nicoletti

Abstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Towards Clinical Translation of CD8International journal of molecular sciences · 2019
    Review
  3. Review
  4. Recent advances in CD8Oncology letters · 2018
    Review
  5. Article
  6. Memory CD4American journal of translational research · 2017
    Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aditi VarthamanUMRS698 INSERM, Univ Denis Diderot, Sorbonne Paris Cité, Paris, France.
Marc Clement
Jamila Khallou-Laschet
Giulia Fornasa
Anh-Thu Gaston
Michael Dussiot
Giuseppina Caligiuri
Harvey Cantor
Srinivas Kaveri
Antonino Nicoletti

Funding

IMMUNOLOGIC MECHANISMS THAT PREVENT AUTOIMMUNITYR01AI037562 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 1996 to 2021
$9.4M
NIAID NIH HHS R01 AI037562
6 · The paper itself

Abstract

T cell-dependent autoimmune diseases are characterized by the expansion of T cell clones that recognize immunodominant epitopes on the target antigen. As a consequence, for a given autoimmune disorder, pathogenic T cell clones express T cell receptors with a limited number of variable regions that define antigenic specificity. Qa-1, a MHC class I-like molecule, presents peptides from the variable region of TCRs to Qa-1-restricted CD8+ T cells. The induction of Vß-specific CD8+ T cells has been harnessed in an immunotherapeutic strategy known as the "T cell vaccination" (TCV) that comprises the injection of activated and attenuated CD4+ T cell clones so as to induce protective CD8+ T cells. We hypothesized that Qa-1-restricted CD8+ regulatory T cells could also constitute a physiologic regulatory arm of lymphocyte responses upon expansion of endogenous CD4+ T cells, in the absence of deliberate exogenous T cell vaccination. We immunized mice with two types of antigenic challenges in order to sequentially expand antigen-specific endogenous CD4+ T cells with distinct antigenic specificities but characterized by a common Vß chain in their TCR. The first immunization was performed with a non-self antigen while the second challenge was performed with a myelin-derived peptide known to drive experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. We show that regulatory Vß-specific Qa-1-restricted CD8+ T cells induced during the first endogenous CD4+ T cell responses are able to control the expansion of subsequently mobilized pathogenic autoreactive CD4+ T cells. In conclusion, apart from the immunotherapeutic TCV, Qa-1-restricted specialized CD8+ regulatory T cells can also be induced during endogenous CD4+ T cell responses. At variance with other regulatory T cell subsets, the action of these Qa-1-restricted T cells seems to be restricted to the immediate re-activation of CD4+ T cells.

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCells, CulturedEncephalomyelitis, Autoimmune, ExperimentalFemaleHistocompatibility Antigens Class IMiceHistocompatibility Antigens Class IQ surface antigens

Identifiers

PMID21738737
PMCPMC3124544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.